Binaytara Hematology and Breast Cancer Conference, Fresno
We invite cancer care professionals to join the Binaytara Hematology and Breast Cancer Conference, Fresno, a CME-accredited event dedicated to hematology and breast cancer. This in-person conference gathers well known experts in hematology and breast cancer to explore the latest updates and research in these fields. Attendees will gain insights into how recent advancements are reshaping the standard of care for patients with hematologic malignancies and breast cancer. The conference emphasizes a multidisciplinary approach, focusing on integrating cutting-edge developments into patient-centric care.
Healthcare professionals attending this event will have opportunity to engage with leaders and peers in discussions about current research and progress in treating hematologic disorders and breast cancer. The Binaytara conference aims to critically evaluate significant clinical data and expert insights, aiming to enhance patient care and clinical outcomes.
Target Audience
- Hematologists, Oncologists
- Surgeons
- Radiation Oncologists
- Physician Assistants/Nurse Practitioners
- Pharmacists
- Nurses
ORGANIZING COMMITTEE
Course Director:
Binay Shah, MD, MHA - Binaytara Foundation
Co-Chairs:
Haifaa Abdulhaq, MD - UCSF Fresno
Sanjay Hinduja, MD - UCSF Fresno
VENUE INFORMATION
DoubleTree by Hilton Hotel Fresno Convention Center
Learning Objectives
- Review data presented at the ASH2023 and SABCS2023 & discuss their applications in clinical settings.
- Choose new therapeutic options for treating benign and malignant hematologic disorders & breast cancer, understanding appropriate indications and contraindications to these therapeutic approaches.
- Discuss the study design and primary endpoints of recently reported and ongoing trials that have influenced the changes in the standards of care in hematology and breast cancer.
- Integrate evolving diagnostic, prognostic, and therapeutic approaches to managing hematologic disorders and breast cancer patients.
- Individualize management of patients based on emerging data from clinical trials and evolving expert guidelines.
GLOBAL ONCOLOGY PROJECT
To learn more about our ongoing project building a 200-bed cancer hospital in Nepal:
April 20th, 2024
All times are listed in Pacific Time (PT)
07:00 AM – 08:00 AM: Registration, Breakfast, & Exhibits
08:00 AM – 08:05 AM Welcome
08:05 AM – 8:20 AM Binaytara Foundation's Efforts in Improving Cancer Care Disparities - Binay Shah, MD, MHA
08:20 AM – 09:50 AM Session 1
Moderator: Xuan Ge, MD, PhD
08:20 AM – 08:45 AM Lymphoma - Joseph Tuscano, MD
08:45 AM – 09:10 AM Chronic Lymphocytic Leukemia - Haifaa Abdulhaq, MD
09:10 AM – 09:35 AM Multiple Myeloma - Alfred Chung, MD
09:35 AM – 09:50 AM Q & A
09:50 AM – 10:20 AM Break & Exhibits
10:20 AM – 12:15 PM Session 2
Moderator: Matthew Frank, MD, PhD
10:20 AM – 10:30 AM AML Case - Cathy Zhang, MD
10:30 AM – 10:50 AM MDS/Acute Leukemia - Aaron Logan, MD, PhD
10:50 AM – 11:10 AM Myeloproliferative Neoplasms and CML - Mohammed Bukari, MD, FACP
11:10 AM – 11:30 AM Cellular Therapy in Hematologic Malignancies – Recent Updates - Vanessa Kennedy, MD
11:30 AM – 11:45 AM Case 1 - Long Term Toxicities/Management of Cellular Therapy - Matthew Frank, MD, PhD
11:45 AM – 12:00 PM Case 2 - Access to Cellular Therapy - Challenges - Naseem Esteghamat, MD, MS
12:00 PM – 12:15 PM Q & A
12:15 PM – 01:15 PM Lunch & Exhibits
01:15 PM – 02:45 PM Session 3
Moderator: L. Lisa Ge, MD
01:15 PM – 01:40 PM Triple Negative Breast Cancer - Christos Vaklavas, MD
01:40 PM – 02:05 PM Hormone Receptor Positive Breast Cancer - Karen S. Anderson, MD, PhD
02:05 PM – 02:30 PM HER2 Positive Breast Cancer - Mark Pegram, MD
02:30 PM – 02:45 PM Q & A
02:45 PM – 03:00 PM Break & Exhibits
03:00 PM – 04:35 PM Session 4
Moderator: Andy S. Jang, MD
03:00 PM – 03:25 PM Radiotherapy – Best Breast Practice - Long N. Pham, MD
03:25 PM – 03:35 PM Q & A
Case 1 – DCIS - Jaspreet Kaur, MD
Case 2 – Inflammatory Breast Cancer - Parminder Sidhu, MD
Case 3 – Early Stage Breast Cancer - Jankikeerthika Dharmarpandi, MD
04:35 PM – 04:40 PM Adjourn
If you are attending this meeting and need to reserve a hotel room, please reserve your room before the cutoff date, April 8th, at the DoubleTree by Hilton Hotel Fresno Convention Center using the link below to take advantage of the discounted group rate of $189 per night plus applicable taxes and fees:
IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:
All conflict of interest has been identified and mitigated for individuals in control of contents.
PLANNING COMMITTEE DISCLOSURE STATEMENT:
None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.
Binay Shah, MD, MHA
Haifaa Abdulhaq, Clinical Professor, UCSF. Director of Hematology, UCSF Fresno. Director of Hematolog/Oncology Fellowship, UCSF Fresno
Sanjay Hinduja
Karen Anderson, Professor, Arizona State University, Mayo Clinic Arizona
Mohammed BUKARI
Alfred Chung, Assistant Professor
Vanessa Kennedy, MD
Aaron Logan, MD, PhD
Mark Pegram, MD
Nhat-Long Pham
Joseph Tuscano, md
Christos Vaklavas, M.D., Associate Professor
Jankikeerthika Dharmarpandi
Naseem Esteghamat, MD, MS
Jaspreet Kaur, MD
Parminder sidhu
Cathy Zhang
Matthew Frank, MD PhD
Li Ge, MD
Xuan Ge, MD, PhD
Andy Jang, Assistant Professor of Medicine
Available Credit
- 6.50 ABIM MOC IISuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.50 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 6.50 AMA PRA Category 1 Credit™The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 6.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 6.50 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
- 6.50 Nursing Contact HoursProvider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.50 Contact Hours.
If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information
Price
POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE:
All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place.
The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference. The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees.
If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.
Violating this policy will result in a fine equivalent to a general display fee for that conference.
If your company has purchased an exhibit or sponsorship, please register at the link below to receive the discounted registration fees:
Link to register as an additional rep of a sponsoring company: https://education.
NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:
If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:
- If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
- If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event.
- If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event.
Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.
CANCELLATION POLICY
You may cancel your enrollment at any time. Cancellation fees apply as below:
- 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
- No refunds will be issued if registration is canceled after that date.
No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.